0 Комментарии
0 Поделились
153 Просмотры
0 предпросмотр
Поиск
Знакомьтесь и заводите новых друзей
- Войдите, чтобы отмечать, делиться и комментировать!
- Hematology Analyzers and Reagents Market to Grow at 6.70% CAGR Through 2031 | Key Players: Danaher, Abbott Laboratories, Shenzhen Mindray, Bio-Rad Laboratories, HORIBA MedicalHematology analyzers and reagents are essential tools in clinical laboratories for the diagnosis and monitoring of blood-related disorders, including anemia, leukemia, infections, and clotting abnormalities. These analyzers provide accurate, rapid, and automated blood counts, reducing manual errors and improving laboratory efficiency. Increasing prevalence of blood disorders, rising demand for...0 Комментарии 0 Поделились 116 Просмотры 0 предпросмотр
- Hematology Market Size Projected to Reach USD 13.74 Billion by 2033 from USD 7.41B in 2024According to DataM Intelligence, the global Hematology Market was valued at USD 7.41 billion in 2024 and is projected to reach USD 13.74 billion by 2033, registering a CAGR of 7.1% during the forecast period. The market growth is fueled by technological advancements in hematology analyzers, rising awareness about early disease detection, and increasing adoption of automated testing...0 Комментарии 0 Поделились 87 Просмотры 0 предпросмотр
- Point‑of‑Care Hematology Advances Fuel Market ExpansionThe Hematology Analyzers and Reagents Market size was valued at USD 8,264.20 million in 2021 and is estimated to grow at a compound annual growth rate (CAGR) of 6.70% over the forecast period from 2024 to 2031. This substantial expansion is fueled by a confluence of factors including rising prevalence of blood disorders, a growing geriatric population, technological advancements in diagnostic...0 Комментарии 0 Поделились 301 Просмотры 0 предпросмотр
- Sickle Cell Disease Market Overview, Growth Analysis, Trends and Forecast By 2031"Executive Summary Sickle Cell Disease Market Size, Share, and Competitive Landscape The Global Sickle Cell Disease Market size in 2023 is USD 2.79 billion. The market share is projected to grow at a CAGR of 13.21% and reach USD 7.52 billion by 2031. An exceptional Sickle Cell Disease Market research document can be formulated well with the blend of top attributes such as highest level of...0 Комментарии 0 Поделились 17 Просмотры 0 предпросмотр
Расширенные страницы